Fennec Pharmaceuticals (NASDAQ: FENC), a small–stage biotechnology Company, announced the grant of a patent 10,596,190 entitled “Method for Reducing Ototoxicity in Pediatric Patients Receiving Platinum-Based Chemotherapy.” by the U.S. Patent and Trademark Office. The Company’s PEDMARK, which uses the patented technology, is a novel formulation...
The Global Stock markets are currently facing the fallout from wide-spread pandemonium owing to the coronavirus scare. The outbreak has affected trade and services across the globe, with companies having to step back and access the full impact of the situation. However there are some...
Zosano Pharma (NASDAQ: ZSAN), a clinical-stage biopharmaceutical Company, announced the acceptance of the Company’s New Drug Application for Qtrypta™, a proprietary formulation of Zolmitriptan by the U.S Food and Drug Administration (FDA) for filing and substantive review. The FDA has set a The Prescription Drug...
Altimmune Inc (NASDAQ: ALT), a clinical stage biotechnology Company developing immunotherapies for unmet medical needs, announced that the Company has completed designing and synthesis of a novel single-dose, intranasal vaccine to protect against COVID-19, developed using its proprietary intranasal vaccine technology. [caption id="attachment_20787" align="aligncenter" width="271"] Image...
Fabry Disease also known as angiokeratoma corporis diffusum or alpha-galactosidase A deficiency, is an inherited disorder characterized by the buildup of globotriaosylceramide, a type of fat in the body’s cells and results in numerous disorders such as acroparesthesias (burning, tingling, or prickling sensation in extremities),...
Alphatec Holdings (NASDAQ: ATEC), a medical technology company developing novel surgical products for treatment of spine disorders, announced the signing of an agreement to acquire EOS imaging, SA (EPA: EOSI), a leader in orthopedic medical imaging and software solutions, in a deal involving cash and...
Veru Inc (NASDAQ: VERU), an oncology and urology focused biopharmaceutical Company developing novel therapeutics for the treatment of prostate cancer, announced the initiation of a pivotal Phase 2 clinical trial of VERU-111, a first-in-class, oral, selective antitubulin agent, intended for the treatment of metastatic castration...
WISekey International Holdings (NASDAQ: WKEY), a premier global cyber security and IOT Company, announced that its plans to showcase the Company’s IoT beacon, which is an ultra-low-power Bluetooth 5 secure beacon, designed for various industrial IoT applications in areas such as cold chain monitoring, heathcare,...
Baudax Bio (NASDAQ: BXRX), a pharmaceutical Company developing novel therapeutics for Acute Care Settings, announed the approval of a New Drug Application ( NDA) for ANJESO (meloxicam injection), intended for alleviating moderate to severe pain, either as a standalone treatment or in combination with other...
Foresight Autonomous Holdings (NASDAQ: FRSX), a Company that develops in-line-of-sight and beyond-line-of-sight sensor and vision systems for the automotives industry, announced the sale of a prototype of its QuadSight® four-camera vision system, intended for use in semi-autonomous and autonomous vehicles. The order has been received...
